Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-65355394 是一种有效的 O-GlcNAc 水解酶 (OGA) 抑制剂,是一种 OGA 化学探针。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,300 | 现货 | ||
5 mg | ¥ 3,250 | 现货 | ||
10 mg | ¥ 4,750 | 现货 | ||
25 mg | ¥ 7,480 | 现货 | ||
50 mg | ¥ 9,870 | 现货 | ||
100 mg | ¥ 13,600 | 现货 |
产品描述 | JNJ-65355394 is an effective O-GlcNAc hydrolase (OGA) inhibitor and an OGA chemical probe. |
靶点活性 | GPR139 (human):16 ± 6 nM(EC50), GTPγS:17 ± 4 Nm(EC50) |
体外活性 | JNJ-63533054 induced luciferase activity against zebrafish GPR139 in a concentration-dependent manner. For zebrafish GPR139, the maximal induction of 3.3-fold of vehicle control was achieved at a concentration of 128nM. From the dose-response curve, the half effective maximal concentration (EC50) values of JNJ-63533054 to zebrafish GPR139 was 3.91nM.[1] |
体内活性 |
JNJ-63533054 specifically activates human GPR139 in the calcium mobilization (EC50 = 16 ± 6 nM) and GTPγS binding (EC50 = 17 ± 4 nM) assays. JNJ-63533054 also activates the rat and mouse GPR139 receptor with similar potency (rat EC50 = 63 ± 24 nM, mouse EC50 = 28 ± 7 nM). [2] JNJ-63533054 crosses the rat blood-brain barrier after oral administration and achieves exposure in the micromolar range. JNJ-63533054 administration decreases spontaneous locomotor activity in rats.[2] |
分子量 | 358.5 |
分子式 | C19H26N4OS |
CAS No. | 2230598-99-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (83.68 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.7894 mL | 13.947 mL | 27.894 mL | 69.735 mL |
5 mM | 0.5579 mL | 2.7894 mL | 5.5788 mL | 13.947 mL | |
10 mM | 0.2789 mL | 1.3947 mL | 2.7894 mL | 6.9735 mL | |
20 mM | 0.1395 mL | 0.6974 mL | 1.3947 mL | 3.4868 mL | |
50 mM | 0.0558 mL | 0.2789 mL | 0.5579 mL | 1.3947 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
JNJ-65355394 2230598-99-7 Others JNJ65355394 JNJ 65355394 Inhibitor inhibitor inhibit